214 related articles for article (PubMed ID: 34276212)
1. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy.
Tan R; Tian D; Liu J; Wang C; Wan Y
Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212
[TBL] [Abstract][Full Text] [Related]
2. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
[TBL] [Abstract][Full Text] [Related]
3. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
[TBL] [Abstract][Full Text] [Related]
4. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
[TBL] [Abstract][Full Text] [Related]
5. Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.
Hu H; Li Y; Zhou Q; Ao Y; Yu C; Wan Y; Xu H; Li Z; Yang X
ACS Appl Mater Interfaces; 2016 Nov; 8(45):30833-30844. PubMed ID: 27791359
[TBL] [Abstract][Full Text] [Related]
6. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin.
Huan M; Zhang B; Teng Z; Cui H; Wang J; Liu X; Xia H; Zhou S; Mei Q
PLoS One; 2012; 7(9):e44116. PubMed ID: 23028490
[TBL] [Abstract][Full Text] [Related]
8. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
9. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
10. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
11. Cascade-Targeting of Charge-Reversal and Disulfide Bonds Shielding for Efficient DOX Delivery of Multistage Sensitive MSNs-COS-SS-CMC.
Cui L; Liu W; Liu H; Qin Q; Wu S; He S; Zhang Z; Pang X; Zhu C
Int J Nanomedicine; 2020; 15():6153-6165. PubMed ID: 32884269
[TBL] [Abstract][Full Text] [Related]
12. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
[TBL] [Abstract][Full Text] [Related]
13. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
14. Possible contribution of sialic acid to the enhanced tumor targeting efficiency of nanoparticles engineered with doxorubicin.
Lee SY; Nam S; Koo JS; Kim S; Yang M; Jeong DI; Hwang C; Park J; Cho HJ
Sci Rep; 2020 Nov; 10(1):19738. PubMed ID: 33184416
[TBL] [Abstract][Full Text] [Related]
15. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
[TBL] [Abstract][Full Text] [Related]
16. Diselenide-triggered hydroxyethyl starch conjugate nanoparticles with cascade drug release properties for potentiating chemo-photodynamic therapy.
Tan R; Ge J; Wang C; Wan Y; Yang X
Carbohydr Polym; 2023 Jul; 311():120748. PubMed ID: 37028875
[TBL] [Abstract][Full Text] [Related]
17. Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin.
Nguyen CT; Tran TH; Amiji M; Lu X; Kasi RM
Nanomedicine; 2015 Nov; 11(8):2071-82. PubMed ID: 26169153
[TBL] [Abstract][Full Text] [Related]
18. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity.
Ren G; Duan D; Wang G; Wang R; Li Y; Zuo H; Zhang Q; Zhang G; Zhao Y; Wang R; Zhang S
Colloids Surf B Biointerfaces; 2022 Sep; 217():112614. PubMed ID: 35700564
[TBL] [Abstract][Full Text] [Related]
19. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
[TBL] [Abstract][Full Text] [Related]
20. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
